Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Pliant Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PLRX.
You can purchase shares of Pliant Therapeutics (NASDAQ:PLRX) through any online brokerage.
Other companies in Pliant Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA), Universe Pharmaceuticals (NASDAQ:UPC), Neumora Therapeutics (NASDAQ:NMRA) and Nutriband (NASDAQ:NTRB).
Pliant Therapeutics has a consensus price target of $21.46.
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $1.2801 last updated April 11, 2025 at 4:10 PM EDT.
There are no upcoming dividends for Pliant Therapeutics.
Pliant Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.
There is no upcoming split for Pliant Therapeutics.
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.